Comparing oncologic outcomes in patients undergoing surgery for oncocytic neoplasms, conventional oncocytoma, and chromophobe renal cell carcinoma.

Autor: Flack CK; Departments of Urology, Indiana University School of Medicine, Indianapolis, IN., Calaway AC; Departments of Urology, Indiana University School of Medicine, Indianapolis, IN., Miller BL; Department of Urology, University of Wisconsin School of Medicine, Madison, WI., Picken MM; Departments of Pathology, Loyola University School of Medicine, Maywood, IL., Gondim DD; Departments of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN., Idrees MT; Departments of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN., Abel EJ; Department of Urology, University of Wisconsin School of Medicine, Madison, WI., Gupta GN; Departments of Urology, Loyola University School of Medicine, Maywood, IL., Boris RS; Departments of Urology, Indiana University School of Medicine, Indianapolis, IN. Electronic address: rboris@iupui.edu.
Jazyk: angličtina
Zdroj: Urologic oncology [Urol Oncol] 2019 Nov; Vol. 37 (11), pp. 811.e17-811.e21. Date of Electronic Publication: 2019 Aug 23.
DOI: 10.1016/j.urolonc.2019.06.002
Abstrakt: Introduction: Oncocytic neoplasms are renal tumors similar to oncocytoma, but their morphologic variations preclude definitive diagnosis. This somewhat confusing diagnosis can create treatment and surveillance challenges for the treating urologist. We hypothesize that these subtle morphologic variations do not drastically affect the malignant potential of these tumors, and we sought to demonstrate this by comparing clinical outcomes of oncocytic neoplasms to those of classic oncocytoma and chromophobe.
Methods: We gathered demographic and outcomes data for patients with variant oncocytic tumors. Oncologic surveillance was conducted per institutional protocol in accordance with NCCN guidelines. Descriptive statistics were used to compare incidence of metastasis and death against those for patients with oncocytoma and chromophobe. Three hundred and fifty-one patients were analyzed: 164 patients with oncocytoma, 28 with oncocytic neoplasms, and 159 with chromophobe tumors.
Results: Median follow-up time for the entire cohort was 32.4 months, (interquartile range 9.2-70.0). Seventeen total patients (17/351, 4.9%) died during the course of the study. In patients with oncocytoma or oncocytic neoplasm, none were known to metastasize or die of their disease. Only chromophobe tumors >6 cm in size in our series demonstrated metastatic progression and approximately half of these metastasized tumors demonstrated sarcomatoid changes.
Conclusion: Variant oncocytic neoplasms appear to have a natural course similar to classic oncocytoma. These tumors appear to have no metastatic potential, and oncologic surveillance may not be indicated after surgery.
(Copyright © 2019 Elsevier Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: